Azienda Ospedaliero-Universitaria Sant'Anna
- Address
- Via Aldo Moro, 8, Cona, 44124 Ferrara, Italy
Cardiovascular Diseases
At Azienda Ospedaliero-Universitaria Sant'Anna, clinical research in cardiovascular diseases focuses on improving outcomes for people with acute myocardial infarction and related heart conditions. The studies are designed to assess whether new treatment strategies can reduce serious events and better support recovery after a cardiac episode.
- Evaluating a new approach to lower the risk of death or unplanned hospital admission after a heart event
- Studying treatment effectiveness in acute myocardial infarction care
This work reflects a strong interest in advancing practical therapies that may improve long-term cardiovascular care in real-world settings.
Neoplasms
The site also conducts oncology research within neoplasms, with studies centered on ovarian cancer, fallopian tube cancer, primitive peritoneal cancer, and early breast cancer. These trials aim to refine maintenance treatment, compare treatment sequencing, and better understand which patient or tumor features may influence outcomes.
- Testing maintenance therapy for BRCA wild-type advanced ovarian cancer and related gynecologic cancers
- Comparing sequential and concurrent treatment strategies in early breast cancer
- Exploring biomarkers and clinical factors that may help predict treatment benefit in cancer care
Research in the U.O di Oncologia Clinica is focused on improving disease control and helping tailor treatment choices for patients with different cancer types.
Bacterial Infections and Mycoses
Clinical trial activity in bacterial infections and mycoses is represented here through critical care research involving adult critically ill patients who require non-invasive mechanical ventilation or invasive mechanical ventilation. The main purpose is to evaluate whether more careful oxygen management can improve survival in severely ill patients.
- Assessing oxygen administration strategies in mechanically ventilated critically ill patients
- Studying ways to improve survival in intensive care settings
This line of research aims to support safer, more effective supportive care for patients facing life-threatening illness.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Azienda Ospedaliero-Universitaria Sant'Anna
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy of Evolocumab Versus Standard Care in LDL-C Reduction for Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention | Assistance Publique Hopitaux De Paris | Phase III | Recruiting | Sep 2021 | — |
IMP list
lock Showing 1 of 14 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Anastrozole | 1 | Unknown | 2025-02-03 | 2025-02-03 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.